| Cat.No. | Name | Information |
|---|---|---|
| M53464 | Herpes virus inhibitor 2 | Herpes virus inhibitor 2 is a herpes virus inhibitor and disrupts herpes virus ribonucleotide reductase quaternary structure. |
| M53463 | HIV Protease Substrate 1 | HIV Protease Substrate 1, a fiuorogenic HIV protease substrate, can be used to study enzymatic activity of HIV protease. |
| M53462 | HIV Protease Substrate I | HIV Protease Substrate I is a chromogenic substrate of HIV-1 protease. |
| M53461 | HIV-1 protease-IN-7 | HIV-1 protease-IN-7 is an orally active HIV-1 protease inhibitor (IC50=3.52 nM, EC50=37 nM). |
| M53460 | SKF107457 | SKF107457 is an HIV-1 protease inhibitor that can be used in AIDS research. |
| M53459 | Mvt-101 | Mvt-101 is a hexapeptide-based inhibitor of HIV-1 protease. |
| M53458 | HPV16-E711-20 epitope | HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. |
| M53457 | HPV16 E7 (86-93) | HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. |
| M53456 | HSV-1 Protease substrate | HSV-1 Protease substrate is a peptide substrate for HSV-1 (Herpes Simplex Virus Type 1) protease, and the specificity constant (kcat/Km) at pH 7.5 for cleavage is 5.2 M-1 s-1. |
| M53455 | FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) | FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) is a FITC labeled HHV-2 Envelope Glycoprotein G (561-578). |
| M53454 | GLR-19 | GLR-19 is an anti-HIV peptide. |
| M53453 | Influenza A NP(366-374) Strain A/PR/8/35 | Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein. |
| M53452 | Influenza Matrix Protein (61-72) | Influenza Matrix Protein (61-72) is a peptide fragment derived from matrix protein of influenza viruses, corresponds to amino acids 61-72. |
| M53451 | NS2 (114-121), Influenza | NS2 (114-121), Influenza, the 114-121 fragment of influenza nonstructural protein 2 (NS2), is a influenza-derived epitope. |
| M53450 | Influenza HA (110-119) | Influenza HA (110-119) is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation. |
| M53449 | Influenza NP (147-155) | Influenza NP (147-155) is a Kd restricted epitope from influenza nucleoprotein. |
| M53448 | CEF1, Influenza Matrix Protein M1 (58-66) | CEF1, Influenza Matrix Protein M1 (58-66) is an epitope derived from the matrix protein of the influenza A virus. |
| M53447 | CEF7, Influenza Virus NP (380-388) | CEF7, Influenza Virus NP (380-388) is a HLA-B*08 restricted influenza virus nucleoprotein epitope. |
| M53446 | CEF8, Influenza Virus NP (383-391) | CEF8, Influenza Virus NP (383-391), an influenza A virus nucleoprotein containing residues 383 to 391, is the most important HLA-B*2705-restricted epitope in the nucleoprotein of influenza A viruses. |
| M53445 | Fusion Inhibitory Peptide | Fusion Inhibitory Peptide (Z-D-Phe-Phe-Gly-OH, FIP, Virus Replication Inhibitory Peptide) is a potent inhibitor of the virus replication, by inhibiting the membrane fusing activity of a viral glycoprotein. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
